Search - tctmd.com

Displaying 741 - 760 of 832

Sort: Relevancy | Date

News Daily News

No Long-term Decline in Cognitive Performance After TAVR

Jason Kahn

October 25, 2013

News Daily News

No Hay Descenso del Rendimiento Cognitivo a Largo Plazo tras una TAVR

Jason Kahn

October 25, 2013

News Daily News

Un Estudio Avala la Angioplastia previa a la Implantación Transcutánea de la Válvula Pulmonar

Yael L. Maxwell

October 04, 2013

News Daily News

Study Argues for Test Angioplasty Before Percutaneous Pulmonary Valve Implantation

Yael L. Maxwell

October 04, 2013

News Daily News

Meta-analysis: Women Fare Better Than Men After TAVR Despite More Complications

Yael L. Maxwell

September 27, 2013

News Daily News

Meta Análisis: A las Mujeres les Va Mejor que a los Hombres tras una TAVR a pesar de tener Más Complicaciones

Yael L. Maxwell

September 27, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

News Daily News

Comparison of Therapies in Multivessel CAD Finds Similar LVEF Preservation at 10 Years

L.A. McKeown

July 24, 2013

News Daily News

La Revascularización Incompleta No Dificulta la TAVR en el Tratamiento de la Estenosis Aórtica Severa

Caitlin E. Cox

July 19, 2013

News Daily News

Incomplete Revascularization Does Not Hinder TAVR for Severe Aortic Stenosis

Caitlin E. Cox

July 19, 2013

News Daily News

Postmarketing Registry Data Show MitraClip Safe, Effective for MR

June 07, 2013

News Daily News

Los Datos de un Registro Postcomercialización revelan que MitraClip es Seguro y Eficaz contra la RM

June 07, 2013

News Industry News

Two Real-World European Studies of Abbott's Minimally Invasive MitraClip® Device Demonstrate Positive Outcomes for Patients with Mitral Regurgitation

June 04, 2013

News Daily News

Tumor Marker Predicts TAVR Outcomes

May 29, 2013

News Daily News

Registry: 1-Year Mortality Similar for TAVR, Surgery in Intermediate-Risk Patients

May 24, 2013

News Daily News

Registro: Mortalidad al Año Similar para la TAVR y la Cirugía en Pacientes de Riesgo Intermedio

May 24, 2013

News Industry News

POSITIVE ANIMAL DATA PRESENTED AT EuroPCR SETS STAGE FOR ADVANCING NEOVASC’S TIARATM TRANSCATHETER MITRAL VALVE INTO HUMAN TRIALS

May 23, 2013

News Daily News

Post-TAVR Coronary Obstruction Risk Low, Linked to Unfavorable Anatomic Features

L.A. McKeown

May 13, 2013

News Daily News

El Bajo Riesgo de Obstrucción Coronaria Post-TAVR se asocia a Características Anatómicas Desfavorables

L.A. McKeown

May 13, 2013

News Conference News SCAI 2013

Live TAVR Cases Pose No Additional Risk for Patients

L.A. McKeown

May 10, 2013

Advertisement

No Long-term Decline in Cognitive Performance After TAVR

No Hay Descenso del Rendimiento Cognitivo a Largo Plazo tras una TAVR

Un Estudio Avala la Angioplastia previa a la Implantación Transcutánea de la Válvula Pulmonar

Study Argues for Test Angioplasty Before Percutaneous Pulmonary Valve Implantation

Meta-analysis: Women Fare Better Than Men After TAVR Despite More Complications

Meta Análisis: A las Mujeres les Va Mejor que a los Hombres tras una TAVR a pesar de tener Más Complicaciones

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

Comparison of Therapies in Multivessel CAD Finds Similar LVEF Preservation at 10 Years

La Revascularización Incompleta No Dificulta la TAVR en el Tratamiento de la Estenosis Aórtica Severa

Incomplete Revascularization Does Not Hinder TAVR for Severe Aortic Stenosis

Postmarketing Registry Data Show MitraClip Safe, Effective for MR

Los Datos de un Registro Postcomercialización revelan que MitraClip es Seguro y Eficaz contra la RM

Two Real-World European Studies of Abbott's Minimally Invasive MitraClip® Device Demonstrate Positive Outcomes for Patients with Mitral Regurgitation

Tumor Marker Predicts TAVR Outcomes

Registry: 1-Year Mortality Similar for TAVR, Surgery in Intermediate-Risk Patients

Registro: Mortalidad al Año Similar para la TAVR y la Cirugía en Pacientes de Riesgo Intermedio

POSITIVE ANIMAL DATA PRESENTED AT EuroPCR SETS STAGE FOR ADVANCING NEOVASC’S TIARATM TRANSCATHETER MITRAL VALVE INTO HUMAN TRIALS

Post-TAVR Coronary Obstruction Risk Low, Linked to Unfavorable Anatomic Features

El Bajo Riesgo de Obstrucción Coronaria Post-TAVR se asocia a Características Anatómicas Desfavorables

Live TAVR Cases Pose No Additional Risk for Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content